Speticemia F1: Speticemia, pneumonia, liver or gallbladder infectios or other internal infections.

1. Bile-duct infection related septicemia: The mortality rate in the treatment group taking F1 and western medicine together was 16.2 percent vs. 38.8 percent in the comparison group using western medicine alone.

2. Pneumonia: 137 pneumonia patients took F1 and over 77 percent resumed to normal temperature in 72 hours.

3. Severe acute bacillary dysentery: 54 severe acute bacillary dysentery patients took F1 and their temperatures resumed to normal in an average of 2.1 days vs. 3.6 days in the comparison group taking regular medicine. The mortality rate in the F1 group was 5.5 percent vs. 10.4 percent in the comparison group.

4. Acute bacillary liver abscess: 30 patients were treated with F1 and the mortality rate was 3.3 percent vs. 15 percent in the comparison group.

5. Bile-duct infection shock: Two reports showed the death rate of the bile-duct infection shock in the F1 group is 15.7 percent vs. 85.7 percent in the western medicine group.

Toxicity and side effect: Patients after taking F1 may have more lose bowel movements, this is normal and should not last for more than a couple of days.